Compare SERA & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SERA | NTIC |
|---|---|---|
| Founded | 2008 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.5M | 83.1M |
| IPO Year | 2021 | 1996 |
| Metric | SERA | NTIC |
|---|---|---|
| Price | $2.03 | $8.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 21.4K | 11.7K |
| Earning Date | 05-06-2026 | 04-09-2026 |
| Dividend Yield | N/A | ★ 0.50% |
| EPS Growth | ★ 32.32 | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $81,000.00 | ★ $84,234,474.00 |
| Revenue This Year | $554.81 | $12.49 |
| Revenue Next Year | $517.27 | $7.64 |
| P/E Ratio | ★ N/A | $400.50 |
| Revenue Growth | ★ 5.19 | N/A |
| 52 Week Low | $1.37 | $7.10 |
| 52 Week High | $4.09 | $10.03 |
| Indicator | SERA | NTIC |
|---|---|---|
| Relative Strength Index (RSI) | 44.54 | 45.05 |
| Support Level | $1.91 | $7.34 |
| Resistance Level | $2.41 | $8.35 |
| Average True Range (ATR) | 0.17 | 0.24 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 26.72 | 25.00 |
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.